Skip to main content
KOMIPHARM INTERNATIONAL CO., LTD. logo

KOMIPHARM INTERNATIONAL CO., LTD. — Investor Relations & Filings

Ticker · 041960 ISIN · KR7041960006 KO Manufacturing
Open in API
Filings indexed 326 across all filing types
Latest filing 2021-03-31 Capital/Financing Update
Country KR South Korea
Listing KO 041960

About KOMIPHARM INTERNATIONAL CO., LTD.

https://komipharm.co.kr/en/

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the decision to issue convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, and the purpose of the funds (debt repayment). This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This document is a formal declaration of the outcomes of a shareholder meeting, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2021-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and confirmation of the auditor's report receipt. While it contains financial data, it is a standardized regulatory disclosure announcement regarding the filing of the audit report rather than the full annual report (10-K) or a standalone audit report document. Given the structure and the nature of the disclosure, it fits best as a Regulatory Filing (RNS). FY 2020
2021-03-17 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) and explicitly states it covers the period from January 1, 2020, to December 31, 2020. It contains comprehensive financial statements, management discussion and analysis, and detailed corporate governance information, which corresponds to the South Korean regulatory requirement for an annual report (10-K equivalent). FY 2020
2021-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Komipharm. It contains the meeting agenda, date, location, and details regarding voting procedures, including electronic voting. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their participation/votes. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2021-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in Korea used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items (such as approval of financial statements), and instructions for electronic/written voting. This falls under the category of Proxy Solicitation & Information Statement (PSI).
2021-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.